Data / Form D filings / Vernal Biosciences, Inc.
Vernal Biosciences, Inc.: Form D filings
Vernal Biosciences, Inc., a biotechnology company in Colchester, VT, filed 3 Form D notices with the SEC between 2021 and 2023. The latest, on June 16, 2023, reports $41 million sold of a $41 million offering to 10 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 261 Mountain View Drive, Colchester, VT, 05461
- Phone
- (512) 791-9680
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2020
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1861147
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 16, 2023 | Amendment | $40,998,390 | $40,998,390 | 10 | May 10, 2022 | sec.gov | |
| May 25, 2022 | New notice | $20,998,407 | $20,998,407 | 10 | May 10, 2022 | sec.gov | |
| May 24, 2021 | New notice | $1,500,000 | $1,500,000 | 9 | Apr 6, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| David Anderson | Director | |
| Daniella Kranjac | Director | |
| Christian Cobaugh | Executive Officer, Director |
Every Form D from the week of Jun 12, 2023 · All recent filings in Vermont · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Vernal Biosciences, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.